§ 50.52. Clinical investigations involving greater than minimal risk but presenting the prospect of direct benefit to individual subjects.
145 words·~1 min read·
/us/cfr/t21/s§ 50.52A research copy — for the controlling text, always check the official state or federal source. Not legal advice.
Any clinical investigation within the scope described in §§ 50.1 and 56.101 of this chapter in which more than minimal risk to children is presented by an intervention or procedure that holds out the prospect of direct benefit for the individual subject, or by a monitoring procedure that is likely to contribute to the subject's well-being, may involve children as subjects only if the IRB finds that:
(a)The risk is justified by the anticipated benefit to the subjects;
(b)The relation of the anticipated benefit to the risk is at least as favorable to the subjects as that presented by available alternative approaches; and
(c)Adequate provisions are made for soliciting the assent of the children and permission of their parents or guardians as set forth in § 50.55. [66 FR 20598, Apr. 24, 2001, as amended at 78 FR 12951, Feb. 26, 2013]
Connections2 cite this
Cited by 2 sections · top 1
Citation graph
cites case law
§ 50.52
Clinical investigations involving greater than minimal risk but presenting the prospect of direct benefit to individual subjects.
Fed. Reg.×2
Cites 0Cited by 2 across 1 source